Century Therapeutics

Century Therapeutics(IPSC)

PHILADELPHIA, PA
Biotechnology1 H-1B visas (FY2023)
WebsiteLinkedInCareers Page

Focus: iPSC Therapy platform

Century Therapeutics is a life sciences company focused on iPSC Therapy platform.

Cell Therapy
Funding Stage
PUBLIC
Open Jobs
10

Products & Portfolio (1)

P.A.S. SODIUM
aminosalicylate sodium
Pre-Launch
ORAL · POWDER

Pipeline & Clinical Trials

Non-Menthol Very Low Nicotine Cigarettes
Tobacco Use
N/A
Clinical Trials (1)
NCT03571724A Study to Assess Changes in Cigarette Consumption During a Switch to Very Low Nicotine Cigarettes
N/A
PDO suture
Wrinkles
N/A
Clinical Trials (1)
NCT07068061PER-SAF_PDOS (Performance and Safety of Polydioxanone Suture)
N/A
N/A
Clinical Trials (1)
NCT02903862Health-eBrain Study
N/A
An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
Stroke
N/A
Clinical Trials (1)
NCT04775836An EHR-based Platform To Facilitate Outcomes and Research Methods in Cerebrovascular Diseases
N/A
N/A
Clinical Trials (1)
NCT05768269A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
N/A
ForeSite PT™ system
Pressure Ulcer
N/A
Clinical Trials (1)
NCT02325388Pressure Sensing to Reduce the Risk of Pressure Ulcer Formation
N/A
electronic discharge communication tool
Other Diagnoses, Comorbidities, and Complications
N/A
Clinical Trials (1)
NCT01402609Assessing the Efficacy of an Electronic Discharge Communication Tool
N/A
Computed Tomography Derived Fractional Flow Reserve for Coronary Hemodynamic Ischemia Noninvasive As
Coronary Artery Disease
N/A
Clinical Trials (1)
NCT03692936Computed Tomography Derived Fractional Flow Reserve for Coronary Hemodynamic Ischemia Noninvasive Assessment
N/A
N/A
Clinical Trials (1)
NCT04420728Closed-Loop Insulin in Mothers With Type 1 Diabetes and Baby Feeding Practices
N/A
Phase 1
Clinical Trials (1)
NCT05336409A Study of CNTY-101 in Participants With CD19-Positive B-Cell Malignancies
Phase 1
Phase 1
Clinical Trials (1)
NCT06255028A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases
Phase 1
VLN menthol cigarettes
Tobacco Use
Phase 1
Clinical Trials (1)
NCT03559725Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes
Phase 1
VLN cigarettes
Tobacco Use
Phase 1
Clinical Trials (1)
NCT03559751Evaluation of the Abuse Liability of Very Low Nicotine (VLN) Cigarettes
Phase 1
X-22 Smoking Cessation Product
Smoking Cessation
Phase 2
Clinical Trials (1)
NCT01400815Randomized Trial to Evaluate the Effectiveness of X-22 as a Smoking Cessation Aid
Phase 2
Stromal-vascular fraction
Knee Osteoarthritis
Phase 2
Clinical Trials (1)
NCT04050111The Evaluation of Safety and Effectiveness of Intraarticular Administration of Autologous Stromal-Vascular Fraction of Adipose Tissue Cells for Treatment of Knee Joint Arthrosis
Phase 2
Aspirin 75 mg daily
Intracerebral Haemorrhage
Phase 3
Clinical Trials (1)
NCT07243704Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage
Phase 3

Open Jobs (10)

Research Associate/Sr. Research Associate, Drug Product Development

Branchburg, NJ
1w ago

Research Associate/Sr. Research Associate, Process Development

Branchburg, NJ
1w ago

Senior Research Associate, Beta Islet Differentiation

Watertown, MA
Research & Development
2w ago

Director Level (level TBD based on experience), Analytical Development

Branchburg, NJ
4w ago

Associate Director, Financial Planning & Analysis

Philadelphia, PA
1mo ago

Associate Director, Translational Sciences

Watertown, MA
1mo ago

Associate Scientist or Scientist, Discovery Biology

Watertown, MA
1mo ago

Senior or Executive Medical Director

Philadelphia/Boston/Branchburg, NJ
1mo ago

Head, Medical Affairs

Philadelphia/Boston/Branchburg, NJ
Clinical Development
1mo ago

Scientist or Senior Scientist, Computational Biology & Data Sciences

Boston, MA
3mo ago
Interview Prep Quick Facts
Portfolio: 1 approved product, 16 clinical trials
Top TAs: Neurology, Oncology, Cardiovascular
H-1B (2023): 1 approval
SEC Filings: 2 available
Open Roles: 10 active jobs
Portfolio Health
Pre-Launch1 (100%)
1 total products
Therapeutic Area Focus
Neurology
2 pipeline
Oncology
2 pipeline
Cardiovascular
1 pipeline
Immunology
1 pipeline
Marketed
Pipeline

Financials (FY2025)

Revenue
$7M195%
R&D Spend
$107M(1628%)16%
Net Income
-$127M
Cash
$58M
Source: SEC 10-K Filing

Hiring Trend

Stable
10
Open Roles
+2
Added
-0
Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas
H-1B Petitions (FY2023)
1
Approved
0
Denied
100%
Rate

Source: USCIS H-1B Employer Data Hub